A clinically viable approach to restoring visual function using optogenetic gene therapy

Optogenetic gene therapies offer a promising strategy for restoring vision to patients with retinal degenerative diseases, such as retinitis pigmentosa (RP). Several clinical trials have begun in this area using different vectors and optogenetic proteins (Clinical Identifiers: NCT02556736, NCT033263...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Boyuan, Viswanathan, Suresh, Brodie, Scott E., Deng, Wen-Tao, Coleman, Kirsten E., Hauswirth, William W., Nirenberg, Sheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213293/
https://www.ncbi.nlm.nih.gov/pubmed/37251979
http://dx.doi.org/10.1016/j.omtm.2023.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213293/
https://www.ncbi.nlm.nih.gov/pubmed/37251979
http://dx.doi.org/10.1016/j.omtm.2023.05.005

Ejemplares similares